US equities |
NVDA $238.90 ▲+2.12% SPCX $171.09 ▲+7.63% MU $1,063.96 ▼-1.02% TSLA $378.73 ▲+2.20% WBD $30.95 ▲+0.03% MSFT $525.18 ▲+1.48% AAPL $332.89 ▼-0.24% META $741.90 ▲+1.90%
FinancialContent

Cabaletta Bio, Inc. - Common Stock (NQ:CABA)

2.080 +0.080 (+4.00%)
Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cabaletta Bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Cabaletta Bio Announces Proposed Public Offering of Common Stock
From Cabaletta Bio
Via GlobeNewswire
News headline image
Why RH Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers GD Culture Group Limited (NASDAQ: GDC) shares climbed 121.9% to $9.63 after gaining over 8% on Monday. GD Culture recently announced an $11.55 million registered direct offering. 
Via Benzinga
News headline image
Recap: Cabaletta Bio Q1 Earnings ↗
 
Via Benzinga
Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 5/2
Via Investor Brand Network
News headline image
Stratasys, Navitas Semiconductor, United Insurance And Other Big Stocks Moving Higher On Tuesday ↗
U.S. stocks traded mostly lower, with the Dow Jones dropping around 200 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Cabaletta Bio Receives FDA Clearance of IND Application for CABA-201 for Treatment of Myositis
From Cabaletta Bio
Via GlobeNewswire
News headline image
Cabaletta Bio Reports First Quarter 2023 Financial Results and Provides Business Update
From Cabaletta Bio
Via GlobeNewswire
News headline image
Cabaletta Bio to Present at the American Society of Gene and Cell Therapy 26th Annual Meeting
From Cabaletta Bio
Via GlobeNewswire
News headline image
Where Cabaletta Bio Stands With Analysts ↗
 
Via Benzinga
News headline image
Cabaletta Bio Receives FDA Fast Track Designation for CABA-201
From Cabaletta Bio
Via GlobeNewswire
News headline image
Cabaletta Bio to Present at the H.C. Wainwright BioConnect Investor Conference at NASDAQ
From Cabaletta Bio
Via GlobeNewswire
News headline image
Cabaletta Bio to Present at the 22nd Annual Needham Virtual Healthcare Conference
From Cabaletta Bio
Via GlobeNewswire
News headline image
Where Cabaletta Bio Stands With Analysts ↗
 
Via Benzinga
News headline image
Why Y-mAbs Therapeutics Shares Are Trading Higher By 50%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Gainers Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) climbed 49.9% to $4.93 after the company posted a profit for the fourth quarter. 
Via Benzinga
News headline image
Cabaletta Bio Receives FDA Clearance of IND Application for CABA-201 for Treatment of Systemic Lupus Erythematosus
From Cabaletta Bio
Via GlobeNewswire
News headline image
Why Titan Machinery Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) shares jumped 40.2% to $2.5109 after the company announced the successful completion of a Phase 2A clinical trial evaluating the safety and efficacy... 
Via Benzinga
News headline image
Cabaletta Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
From Cabaletta Bio
Via GlobeNewswire
News headline image
Cabaletta Bio to Present at the Cowen 43rd Annual Health Care Conference
From Cabaletta Bio
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2023 ↗
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
Autolus Therapeutics Announces Collaboration with Cabaletta Bio for Use of Autolus’ Safety Switch System in Cell Therapies for Autoimmune Disease
From Autolus Therapeutics plc
Via GlobeNewswire
News headline image
Cabaletta Bio to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Cabaletta Bio
Via GlobeNewswire
News headline image
Why Applied Molecular Transport Shares Are Trading Lower By Over 55%? Here Are 47 Stocks Moving In Friday's Mid-Day Session ↗
Gainers 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Cabaletta Bio Announces $35 Million Offering
From Cabaletta Bio
Via GlobeNewswire
News headline image
Cabaletta Bio to Present at the 5th Annual Evercore ISI HealthCONx Conference
From Cabaletta Bio
Via GlobeNewswire
News headline image
Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday ↗
Gainers Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus... 
Via Benzinga
News headline image
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Freight Technologies, Inc. (NASDAQ: FRGT) shares surged 137% to $0.4901 after analysts at Chardan Capital initiated coverage of the stock with a $2.25 price target. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
Gainers 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >